LFMD Q4 2022 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$182M

Q4 2022 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$28M+2.6% YoY

Gross Profit

$24M85.5% margin

Operating Income

-$10M-36.9% margin

Net Income

-$12M-42.4% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

-10.5%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$26M

Total Liabilities

$33M

Stockholders' Equity

-$7M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$27M	+2.6%
Gross Profit	$24M	$22M	+10.1%
Operating Income	-$10M	-$14M	+24.1%
Net Income	-$12M	-$18M	+34.1%